Tumor - MIB-1 Index for Meningioma Recurrence Risk Stratification

In this episode, we delve into a retrospective study published in Neurosurgical Review in 2026, analyzing 505 patients who underwent subtotal resection of meningiomas. The study investigated the predictive power of the MIB-1 index in assessing recurrence risk. Key findings indicate that a lower MIB-1 index significantly correlates with a reduced likelihood of meningioma recurrence post-subtotal resection. This research offers valuable insights for neurosurgeons in stratifying patient risk and tailoring follow-up strategies. This content is for informational purposes only and does not constitute medical advice. This summary is based on the full text of the study.